Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
61.00
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Top S&P500 movers in Thursday's pre-market session
↗
May 07, 2026
Via
Chartmill
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
May 06, 2026
Via
ACCESS Newswire
These S&P500 stocks are moving in today's session
↗
May 04, 2026
Via
Chartmill
Exploring the top movers within the S&P500 index during today's session.
↗
May 04, 2026
Via
Chartmill
Moderna Inc (NASDAQ:MRNA) Surges Past Q1 Estimates on International Strength
↗
May 01, 2026
Via
Chartmill
MRNA Q1 Deep Dive: International Partnerships and Pipeline Progress Offset Litigation Headwinds
May 02, 2026
Biotechnology company Moderna (NASDAQ:MRNA) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 260% year on year to $389 mil...
Via
StockStory
These S&P500 stocks are moving in today's session
↗
May 01, 2026
Via
Chartmill
Moderna (MRNA) Q1 2026 Earnings Transcript
↗
May 01, 2026
Moderna (MRNA) Q1 2026 Earnings Transcript
Via
The Motley Fool
Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars
May 01, 2026
Biotechnology company Moderna (NASDAQ:MRNA) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 260% year on year to $389 mi...
Via
StockStory
What's going on in today's pre-market session: S&P500 movers
↗
May 01, 2026
Via
Chartmill
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
May 01, 2026
Via
ACCESS Newswire
Moderna (MRNA) Reports Earnings Tomorrow: What To Expect
April 29, 2026
Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday morning. Here’s what you need to know. Moderna beat analysts’ revenue expec...
Via
StockStory
These S&P500 stocks are gapping in today's session
↗
April 24, 2026
Via
Chartmill
3 Healthcare Stocks With the Most Durable Competitive Moats
↗
April 23, 2026
These companies offer a clear path to sustained earnings growth.
Via
The Motley Fool
Topics
Intellectual Property
Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
April 21, 2026
Via
ACCESS Newswire
Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth
↗
April 21, 2026
It will be a turbulent ride, but patient investors might come out of it much richer.
Via
The Motley Fool
Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting
April 21, 2026
Via
ACCESS Newswire
Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19
April 21, 2026
Via
ACCESS Newswire
Moderna to Present at Upcoming Conferences in May 2026
April 21, 2026
Via
ACCESS Newswire
What's Pushing Moderna Stock Higher Today?
↗
April 20, 2026
Moderna (NASDAQ:MRNA) shares are moving higher on Monday after the company won FDA Fast Track status for an oncology program.
Via
Benzinga
Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting
April 17, 2026
Via
ACCESS Newswire
Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026
April 15, 2026
Via
ACCESS Newswire
3 Unpopular Stocks We Approach with Caution
April 14, 2026
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Via
StockStory
A $2 Trillion IPO and the Space Economy
↗
April 10, 2026
We discuss the hottest IPO ever, SpaceX, and what the future of the space economy might look like.
Via
The Motley Fool
Topics
Economy
Initial Public Offering
Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy?
↗
April 09, 2026
These stocks have surged in the double-digits.
Via
The Motley Fool
Topics
Artificial Intelligence
Stocks
3 Mid-Cap Stocks We’re Skeptical Of
April 09, 2026
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...
Via
StockStory
Looks Like M&A Week in 3 Different Sectors
↗
April 08, 2026
Some large merger & acquisition deals that could shake up the consumer goods and the food distribution industry, plus deals in the healthcare industry.
Via
The Motley Fool
You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.
↗
April 07, 2026
Could this player be heading into a new era of growth?
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Stocks
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
April 06, 2026
Via
ACCESS Newswire
2 S&P 500 Stocks with Exciting Potential and 1 We Ignore
April 03, 2026
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
Via
StockStory
Topics
Stocks
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.